These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34307474)

  • 1. More than Nail Deep: The Effect of Efinaconazole 10% Treatment on the Quality of Life in Patients with Onychomycosis: A post hoc Study.
    Gupta AK; Venkataraman M; Quinlan EM; Gupta MA; Anbalagan N; Lyons R
    Skin Appendage Disord; 2021 Jun; 7(4):272-279. PubMed ID: 34307474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of onychomycosis with efinaconazole 10% topical solution and quality of life.
    Tosti A; Elewski BE
    J Clin Aesthet Dermatol; 2014 Nov; 7(11):25-30. PubMed ID: 25489379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis.
    Potter LP; Mathias SD; Raut M; Kianifard F; Tavakkol A
    Health Qual Life Outcomes; 2006 Aug; 4():50. PubMed ID: 16911778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
    Elewski BE; Cantrell W; Lin T
    J Drugs Dermatol; 2018 Feb; 17(2):175-178. PubMed ID: 29462225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Follow-up of Onychomycosis Patients Treated With Efinaconazole.
    Pollak RA; Ilie C
    J Drugs Dermatol; 2017 Dec; 16(12):1269-1273. PubMed ID: 29240863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efinaconazole in Onychomycosis.
    Gupta AK; Talukder M
    Am J Clin Dermatol; 2022 Mar; 23(2):207-218. PubMed ID: 34902110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.
    Iozumi K; Abe M; Ito Y; Uesugi T; Onoduka T; Kato I; Kato F; Kodama K; Takahashi H; Takeda O; Tomizawa K; Nomiyama T; Fujii M; Mayama J; Muramoto F; Yasuda H; Yamanaka K; Sato T; Oh-I T; Kasai H; Tsuboi R; Hattori N; Maruyama R; Omi T; Shimoyama H; Sei Y; Nakasu I; Nishimoto S; Hata Y; Mochizuki T; Fukuzawa M; Seishima M; Sugiura K; Katayama I; Yamamoto O; Shindo M; Kiryu H; Kusuhara M; Takenaka M; Watanabe S
    J Dermatol; 2019 Aug; 46(8):641-651. PubMed ID: 31206779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Onychomycosis on Quality of Life: A Systematic Review of the Available Literature.
    Gupta AK; Mays RR
    Skin Appendage Disord; 2018 Oct; 4(4):208-216. PubMed ID: 30410887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efinaconazole 10% and Tavaborole 5% Penetrate Across Poly-ureaurethane 16%: Results of In Vitro Release Testing and Clinical Implications of Onychodystrophy in Onychomycosis.
    Adigun CG; Vlahovic TC; McClellan MB; Thakker KD; Klein RR; Elstrom TA; Ward DB
    J Drugs Dermatol; 2016 Sep; 15(9):1116-20. PubMed ID: 27602975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
    Sugiura K; Sugimoto N; Hosaka S; Katafuchi-Nagashima M; Arakawa Y; Tatsumi Y; Jo Siu W; Pillai R
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Efinaconazole 10% Topical Solution for the Treatment of Onychomycosis.
    Gupta AK; Studholme C
    Skin Therapy Lett; 2016 Nov; 21(6):7-11. PubMed ID: 27825175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
    Elewski BE; Rich P; Pollak R; Pariser DM; Watanabe S; Senda H; Ieda C; Smith K; Pillai R; Ramakrishna T; Olin JT
    J Am Acad Dermatol; 2013 Apr; 68(4):600-608. PubMed ID: 23177180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Center, Prospective, Blinded Study Comparing the Efficacy and Compatibility of Efinaconazole 10% Solution in Treating Onychomycosis with and without Concurrent Nail Polish Use.
    Canavan TN; Bevans SL; Cantrell WC; Wang C; Elewski BE
    Skin Appendage Disord; 2018 Nov; 5(1):9-12. PubMed ID: 30643774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antifungal medication for toenail onychomycosis.
    Kreijkamp-Kaspers S; Hawke K; Guo L; Kerin G; Bell-Syer SE; Magin P; Bell-Syer SV; van Driel ML
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010031. PubMed ID: 28707751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients.
    Vlahovic TC; Gupta AK
    Expert Rev Anti Infect Ther; 2022 Jan; 20(1):3-15. PubMed ID: 34106031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical and device-based treatments for fungal infections of the toenails.
    Foley K; Gupta AK; Versteeg S; Mays R; Villanueva E; John D
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012093. PubMed ID: 31978269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How effective is efinaconazole in the management of onychomycosis?
    Gupta AK; Cernea M
    Expert Opin Pharmacother; 2016; 17(4):611-8. PubMed ID: 26809447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efinaconazole 10% nail solution: a new topical treatment with broad antifungal activity for onychomycosis monotherapy.
    Gupta AK; Paquet M
    J Cutan Med Surg; 2014; 18(3):151-5. PubMed ID: 24800702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.
    Del Rosso JQ
    J Clin Aesthet Dermatol; 2014 Jul; 7(7):10-8. PubMed ID: 25053979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.